PapoianV, MardirossianV, HessDT, et al.Effects of bariatric surgery on facial features. Arch Plast Surg. 2015; 42(5):567–571; doi: 10.5999/aps.2015.42.5.567
2.
RohrichRJ, PessaJE, RistowB. The youthful cheek and the deep medial fat compartment. Plast Reconstr Surg. 2008; 121(6):2107–2112; doi: 10.1097/PRS.0b013e31817123c6
3.
SilveiraSQ, da SilvaLM, de Campos Vieira AbibA, et al.Relationship between perioperative semaglutide use and residual gastric content: A retrospective analysis of patients undergoing elective upper endoscopy. J Clin Anesth. 2023; 87:111091; doi: 10.1016/j.jclinane.2023.111091
4.
RubinoD, AbrahamssonN, DaviesM, et al.Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: The STEP 4 randomized clinical trial. Jama. 2021; 325(14):1414–1425; doi: 10.1001/jama.2021.3224
5.
CostanzoG, CuratoloS, BusàB, et al.Two birds one stone: Semaglutide is highly effective against severe psoriasis in a type 2 diabetic patient. Endocrinol Diabetes Metab Case Rep. 2021; doi: 10.1530/edm-21-0007
6.
SassMR, DanielsenAA, Köhler-ForsbergO, et al.Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: Study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry). BMJ Open. 2023; 13(1):e068652; doi: 10.1136/bmjopen-2022-068652
